Risk factors
MapLight Therapeutics (MPLT) risk factors
Item 1A of every MapLight Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors71 risks
MapLight Therapeutics relies heavily on external funding, having completed an IPO on October 26, 2025, raising $261.6 million net proceeds.
Filed Mar 26, 2026